This review highlights some significant short and long acting non-oral therapies in development or soon to be licensed, which will enhance the armamentarium of our treatment strategies for early and advanced therapy
For patients who have exhausted conventional sleep interventions (sleep hygiene, CBT-I, conventional medications) and remain symptomatic, DSIP represents a speculative option with a plausible mechanism
Typically, MIC B12 injections are administered bi-weekly over a period of several months
Stable gastric pentadecapeptide BPC 157 as a therapy and safety key: a special beneficial pleiotropic effect controlling and modulating angiogenesis and the NO-system
It is essential to distinguish medically indicated B12 replacement therapy from commercially marketed wellness injections, as they serve fundamentally different purposes and are subject to different regulatory oversight
This past spring, multiple officials inside the agency expressed concern that then FDA head Marty Zakary was stacking the hearing with panelists who had direct connections to the peptide industry, according to reporting from the Washington Post published last week
